J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 20,000 shares at $88.01 ($1.8M) on 2021-08-19, disclosed to the SEC on 2021-08-20.
Open-market sale of $1.8M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |